))
Attorney Andrew M. Lieb
Manage episode 302999067 series 2893097
Dean Fanelli and Dr. Dean Fanelli द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री Dean Fanelli and Dr. Dean Fanelli या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal।
My guest today is Andrew M. Lieb - the Managing Attorney of Lieb at Law, P.C., with a practice focus on litigation and regulatory compliance. Mr. Lieb provides a wide range of legal services throughout the New York Metro area on such topics as real estate brokerage license law litigation / compliance, fair housing and discrimination litigation / compliance, employment disputes, residential and commercial landlord / tenant needs. Andrew also does discrimination prevention trainings for companies and discrimination litigation.
Other stories covered include:
72 percent of unvaccinated Americans would quit their job if vaccines are mandated https://thehill.com/changing-america/well-being/prevention-cures/571084-whopping-70-percent-of-unvaccinated-americans
Judge suspends NY state vaccine mandate for health care workers who claim religious exemption https://www.cnn.com/2021/09/14/us/new-york-covid-vaccine-mandate-lawsuit/index.html
Fauci says he would support vaccine requirements for air travel https://thehill.com/policy/healthcare/571902-fauci-says-he-would-support-vaccine-requirements-for-air-travelAbout Dr. Dean Fanelli
Dean Fanelli, Ph.D. is a patent, regulatory, and transactional attorney in the Washington, DC office of Cooley LLP (www.cooley.com) focusing on issues related to the development, protection, and commercialization of biotech and pharmaceutical products. In addition to Dr. Fanelli's expertise relating to legal issues involved in pharma and biotech development, Dr. Fanelli also understands the business needs of his clients as he has co-founded three biotechnology companies: PhosImmune, Inc. an immuno-oncology company, C-Reveal Therapeutics, LLC, an immuno-oncology drug development company focused on exposing tumors to immune responses and therapies, and most recently AexeRNA Therapeutics, LLC, an mRNA company developing advanced Lipid Nanoparticle delivery systems that reduce the side effects present in currently authorized mRNA COVID-19 vaccines. He is a regular on TV & Radio commenting on Covid-19 & Vaccines & also hosts his own podcast “Politics & Life Sciences Radio.”
51 एपिसोडस
साझा करें
